PDS Biotech Executives to Present an Overview of Oncology and Infectious Disease Programs at the World Vaccine & Immunotherapy Congress
Chief Medical Officer, Dr. Lauren V. Wood, to present on the development of targeted immunotherapies for solid tumors based on the Versamune® platform
Related news for (PDSB)
- Breaking News: MoBot’s Latest Update as of 08/25/25 09:00 AM
- MoBot alert highlights: NASDAQ: MLGO, NASDAQ: SNDX, NASDAQ: LTBR, NASDAQ: INEO, NASDAQ: PDSB (05/22/25 07:00 PM)
- MoBot alert highlights: NASDAQ: INEO, NASDAQ: PDSB, NASDAQ: VCIG, NASDAQ: BTM, NASDAQ: BLMZ (05/22/25 06:00 PM)
- PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Today’s Top Performers: MoBot’s Market Review 03/07/25 09:00 AM